These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27497260)

  • 1. Patient and general public preferences for health states: A call to reconsider current guidelines.
    Versteegh MM; Brouwer WBF
    Soc Sci Med; 2016 Sep; 165():66-74. PubMed ID: 27497260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [QALYS or not QALYS: that is the question?].
    Moatti JP; Auquier P; Le Coroller AG; Macquart-Moulin G
    Rev Epidemiol Sante Publique; 1995 Dec; 43(6):573-83. PubMed ID: 8552855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advocating a Paradigm Shift in Health-State Valuations: The Estimation of Time-Preference Corrected QALY Tariffs.
    Jonker MF; Donkers B; de Bekker-Grob EW; Stolk EA
    Value Health; 2018 Aug; 21(8):993-1001. PubMed ID: 30098678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use?
    Gabriel SE; Kneeland TS; Melton LJ; Moncur MM; Ettinger B; Tosteson AN
    Med Decis Making; 1999; 19(2):141-8. PubMed ID: 10231076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are guidelines for measurement of quality of life contrary to patient-centred care?
    Disher T; Beaubien L; Campbell-Yeo M
    J Adv Nurs; 2018 Nov; 74(11):2677-2684. PubMed ID: 30109711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social tariffs and democratic choice-Do population-based health state values reflect the will of the people?
    Schneider PP
    Health Econ; 2021 Jan; 30(1):104-112. PubMed ID: 33067930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple Sclerosis.
    Goodwin E; Green C; Hawton A
    Value Health; 2020 Feb; 23(2):242-250. PubMed ID: 32113630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.
    Shiroiwa T; Saito S; Shimozuma K; Kodama S; Noto S; Fukuda T
    Appl Health Econ Health Policy; 2016 Jun; 14(3):375-85. PubMed ID: 26940671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.
    Lipman SA; Brouwer WBF; Attema AE
    Value Health; 2019 Jul; 22(7):816-821. PubMed ID: 31277829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QALYs, euthanasia and the puzzle of death.
    Barrie S
    J Med Ethics; 2015 Aug; 41(8):635-8. PubMed ID: 25082901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altruistic Preferences in Time Tradeoff: Consideration of Effects on Others in Health State Valuations.
    Krol M; Attema AE; van Exel J; Brouwer W
    Med Decis Making; 2016 Feb; 36(2):187-98. PubMed ID: 26552410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capabilities as menus: a non-welfarist basis for QALY evaluation.
    Bleichrodt H; Quiggin J
    J Health Econ; 2013 Jan; 32(1):128-37. PubMed ID: 23202258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health outcomes in economic evaluation: who should value health?
    Stamuli E
    Br Med Bull; 2011; 97():197-210. PubMed ID: 21285110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public preferences for responsibility versus public preferences for reducing inequalities.
    Edlin R; Tsuchiya A; Dolan P
    Health Econ; 2012 Dec; 21(12):1416-26. PubMed ID: 22072569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of patient and population values for health states in varicose veins patients.
    Ratcliffe J; Brazier J; Palfreyman S; Michaels J
    Health Econ; 2007 Apr; 16(4):395-405. PubMed ID: 17006963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness versus cost-utility analysis of interventions for cancer: does adjusting for health-related quality of life really matter?
    Tengs TO
    Value Health; 2004; 7(1):70-8. PubMed ID: 14720132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating sign-dependence in health-related social welfare functions.
    Attema AE
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):223-8. PubMed ID: 25543906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.